'Hba 1c' diaporamas de présentation

Introduction To Glucose Monitoring In Diabetes Seyed Adel Jahed, M.D., Endocrinologist

Introduction To Glucose Monitoring In Diabetes Seyed Adel Jahed, M.D., Endocrinologist Gabric Diabetes Education Association. 7 th Aug 2019 RIES Tehran, Iran. Agenda. HbA 1c SMBG CGMS. Disclosures. I have taken part in scientific congresses with sponsorship by:

1.08k views • 82 slides

Diabetes mellitus: An update

Diabetes mellitus: An update. D. Hunt March 2010. Significance of diabetes mellitus. 5% of the population has diagnosed diabetes prevalence increases with age: 20 - 44: 1% 45 - 65: 5% > 65: 10%

919 views • 75 slides

Insulin resistance and ? -cell dysfunction are fundamental to type 2 diabetes

952 views • 56 slides

Mohammad E. Khamseh Institute of Endocrinology and Metabolism Iran University of Medical Sciences

12 th International Congress of Endocrine Disorders Beyond HbA1c Glycemic Metrics. Mohammad E. Khamseh Institute of Endocrinology and Metabolism Iran University of Medical Sciences 15 th November 2018 Tehran, Iran. Objectives.

787 views • 44 slides

Initiation of Insulin therapy in Type2 Diabetes

Initiation of Insulin therapy in Type2 Diabetes. Saeid K albasi Ass. Prof. of Endocrinology and metabolism Loghman Hospital. Agenda. ADA-EASD Guideline Why Basal? Selection of Initial Insulin Regimens Basal plus Dosing and Titration.

1.45k views • 43 slides

Developments in the Treatment of T2DM

Developments in the Treatment of T2DM. Dr John Clark. 3 million. 2 million. Type 1. Type 2. 1 million. 0. 2013. 2000. 1995. Diabetes Prevalence. Audit of West Suffolk Hospital In-Patients. One day (23/9/12) 440 in-patients, in total, in WSH that day 75 known to have Diabetes

531 views • 42 slides

Glucose in blood

Glucose in blood. Seminar No. 3 - Chapter 8 -. What is glucose?. the most common monosaccharide, aldohexose C 6 H 12 O 6 ( M r 180) grape sugar, blood sugar, dextrose the most important sugar in the human body the source of chemical energy (17 kJ/g) metabolic nutrient for most tissues

1.13k views • 40 slides

HbA1c as a compass- pointing you to the right diagnosis?

HbA1c as a compass- pointing you to the right diagnosis?. Eric S. Kilpatrick Department of Clinical Biochemistry Hull Royal Infirmary/Hull York Medical School. HbA 1c : Historical Aspects. 1962: Huisman and Dozy

565 views • 40 slides

John B. Buse, MD, PhD Associate Professor of Medicine

Difficulties in Achieving Target A1c Values. John B. Buse, MD, PhD Associate Professor of Medicine Chief, Division of General Medicine and Clinical Epidemiology Director, Diabetes Care Center University of North Carolina Chapel Hill, NC jbuse@med.unc.edu. 12.4%. 37.2% >8%. 7.8%. 63%

574 views • 38 slides

CURSO INTERNACIONAL PARA NUTRICIONISTAS

544 views • 38 slides

Meme Phung Zhi Yuan Quek Alison Wong

Case D - Chronic Diabetes. Meme Phung Zhi Yuan Quek Alison Wong. Mr DM, aged 50 years has NIDDM and asthma. He presents to your pharmacy with a prescription for Rulide 300mg d and Prednisolone 25mg as directed. He takes the following medications on a regular basis: Glibeclamide 5mg BD

501 views • 37 slides

Comparison of metformin and insulin versus insulin alone for type 2 diabetes

In the name of GOD. Comparison of metformin and insulin versus insulin alone for type 2 diabetes. Systematic review of randomised clinical trials with meta-analyses and trial sequential analyses BMJ 2012; 344 doi (Published 19 April 2012) Presented by : Dr.Abna. Case Scenario.

457 views • 35 slides

Journal Club

537 views • 26 slides

Glucose-lowering trials in type 2 diabetes

391 views • 23 slides

326 views • 18 slides

Introduction

Cost-effectiveness of Screening Strategies for Identifying Pediatric Diabetes Mellitus and Dysglycemia.

173 views • 12 slides

DIABETES CARE, VOLUME 32, SUPPLEMENT 1, JANUARY 2009

DIABETES CARE, VOLUME 32, SUPPLEMENT 1, JANUARY 2009. ADA Guidelines 2009: Bariatric Surgery. ? Bariatric surgery should be considered for adults with BMI > 35 kg/m2 and type 2 diabetes, especially if the diabetes is difficult to control with lifestyle and pharmacologic therapy. (B)

288 views • 11 slides

Steno-2: study design

Steno-2: study design. Patents with type 2 diabetes and microalbuminuria (n = 160). Stratification by urinary albumin excretion. Randomisation. Intensive therapy (n = 80). Conventional therapy (n = 80). Stepwise behaviour modification

1.16k views • 7 slides

DURATION-6: Change in glycaemic control from baseline to week 26

110 views • 2 slides

LEAD-6

LEAD-6. Mean change in HbA 1c : -1.12% with liraglutide vs. -0.79% with exenatide (p < 0.0001) Proportion of patients with HbA 1c <7.0%: 54% vs. 43% (p = 0.0015), respectively Weight loss: -3.24 kg vs. -2.87 kg (p = NS), respectively.

180 views • 1 slides